Project cooperationUpdated on 12 December 2025
Integrating RNA-seq and Mechanistically Interpretable Machine Learning for Toxicity Prediction
Professor at Ghent University
Ghent, Belgium
About
In the context of New Approach Methodologies (NAMs), our expertise lies in interpretable machine-learning frameworks that integrate chemical structure information with RNA-seq–based transcriptomic dose–response data to predict biological activity in a mechanistically transparent manner.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Expertise in Human-Relevant NAMs and Advanced Safety Assessment:
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Dalia de la Fuente
Postdoc researcher at University of Burgos
Burgos, Spain
Project cooperation
Expertise in Human-Relevant NAMs and Advanced Safety Assessment
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Laura Gómez Cuadrado
Head of Biomedicine and Cellular Toxicology at University of Burgos
Burgos, Spain
Project cooperation
Translational NAMs in pharmacology & toxicology for drug profiling
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Nikolas Dietis
Assistant Professor of Pharmacology at University of Cyprus
Nicosia, Cyprus